Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

No hiding place for BOB inside myeloma

Hans J. Stauss

Blood (2017) 129 (10): 1236–1237.

https://doi.org/10.1182/blood-2017-01-761510

Published: 2017

Journal Articles

Optimizing T-cell receptor gene therapy for hematologic malignancies

Emma C. Morris, Hans J. Stauss

Blood (2016) 127 (26): 3305–3311.

https://doi.org/10.1182/blood-2015-11-629071

Published: 2016

Journal Articles

Engineered T cells can fight malignant T cells

Hans J. Stauss

Blood (2015) 126 (8): 927–928.

https://doi.org/10.1182/blood-2015-07-652057

Published: 2015

Journal Articles

CD3 limits the efficacy of TCR gene therapy in vivo

Maryam Ahmadi, Judith W. King, Shao-An Xue, Cécile Voisine, Angelika Holler, Graham P. Wright, Jonathan Waxman, Emma Morris, Hans J. Stauss

Blood (2011) 118 (13): 3528–3537.

https://doi.org/10.1182/blood-2011-04-346338

Published: 2011

Journal Articles

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

Sharyn Thomas, Shao-An Xue, Charles R. M. Bangham, Bent K. Jakobsen, Emma C. Morris, Hans J. Stauss

Blood (2011) 118 (2): 319–329.

https://doi.org/10.1182/blood-2010-12-326736

Published: 2011

Journal Articles

Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination

Constandina Pospori, Shao-An Xue, Angelika Holler, Cecile Voisine, Mario Perro, Judith King, Farnaz Fallah-Arani, Barry Flutter, Ronjon Chakraverty, Hans J. Stauss, Emma C. Morris

Blood (2011) 117 (25): 6813–6824.

https://doi.org/10.1182/blood-2010-08-304568

Published: 2011

Journal Articles

DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance

Coralie Chaise, Sarah L. Buchan, Jason Rice, Jeanine Marquet, Hélène Rouard, Mathieu Kuentz, Gisella E. Vittes, Valérie Molinier-Frenkel, Jean-Pierre Farcet, Hans J. Stauss, Marie-Hélène Delfau-Larue, Freda K. Stevenson

Blood (2008) 112 (7): 2956–2964.

https://doi.org/10.1182/blood-2008-02-137695

Published: 2008

Journal Articles

LMP2-Specific TCR Gene Therapy for Hodgkin Lymphoma - Design of a Dominant TCR Construct for Immunotherapy.

Daniel P. Hart, MD, Sharyn Thomas, Shao-an Xue, Emma C. Morris, MD, PhD, Hans J. Stauss, MD, PhD

Blood (2007) 110 (11): 2762.

https://doi.org/10.1182/blood.V110.11.2762.2762

Published: 2007

Journal Articles

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy

Peng H. Tan, Sven C. Beutelspacher, Shao-An Xue, Yao-He Wang, Peter Mitchell, James C. McAlister, D. Frank P. Larkin, Myra O. McClure, Hans J. Stauss, Mary A. Ritter, Giovanna Lombardi, Andrew J. T. George

Blood (2005) 105 (10): 3824–3832.

https://doi.org/10.1182/blood-2004-10-3880

Published: 2005

Includes: Supplemental data

Journal Articles

Immunotargetting of the Wilms’ Tumor WT1 Antigen for Dendritic Cell and B-Cell-Based Vaccination of Leukemia.

Zwi N. Berneman, MD, PhD, Ann Van Driessche, BSc, Peter Ponsaerts, PhD, Liquan Gao, MD, Hans J. Stauss, MD, PhD, Wilfried A. Schroyens, MD, PhD, Ann Van de Velde, MD, Alain Gadisseur, MD, Marc Lenjou, MT, Griet Nijs, MT, Dirk R. Van Bockstaele, PhD, Viggo F. Van Tendeloo, PhD

Blood (2004) 104 (11): 2541.

https://doi.org/10.1182/blood.V104.11.2541.2541

Published: 2004

Journal Articles

Escherichia Coli Expressing Recombinant WT1 Protein and Listeriolysin O Stimulate Antigen-Specific T Cells Following Vaccination in C57BL/6 Mice.

Josianne Nitcheu, Dr, Francisco S. Ramirez-Jimenez, Hans J. Stauss, Georges Vassaux

Blood (2004) 104 (11): 4289.

https://doi.org/10.1182/blood.V104.11.4289.4289

Published: 2004

Journal Articles

Use of B cell–bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen

Philip Savage, Liquan Gao, Kevin Vento, Pam Cowburn, Stephen Man, Neil Steven, Graham Ogg, Andrew McMichael, Agamemnon Epenetos, Els Goulmy, Hans J. Stauss

Blood (2004) 103 (12): 4613–4615.

https://doi.org/10.1182/blood-2003-11-3903

Published: 2004

Journal Articles

TCR gene therapy of leukemia

Hans J. Stauss, Emma C. Morris, Shao-an Xue

Blood (2003) 102 (10): 3462–3463.

https://doi.org/10.1182/blood-2003-09-3020

Published: 2003

Journal Articles

Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity

Persis J. Amrolia, Steven D. Reid, Liquan Gao, Beate Schultheis, Gianpietro Dotti, Malcolm K. Brenner, Junia V. Melo, John M. Goldman, Hans J. Stauss

Blood (2003) 101 (3): 1007–1014.

https://doi.org/10.1182/blood-2002-02-0525

Published: 2003

Journal Articles

Two distinct HLA-A0201–presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL

Ilaria Bellantuono, Liquan Gao, Suzanne Parry, Steve Marley, Francesco Dazzi, Jane Apperley, John M. Goldman, Hans J. Stauss

Blood (2002) 100 (10): 3835–3837.

https://doi.org/10.1182/blood.V100.10.3835

Published: 2002

Journal Articles

Selective elimination of leukemic CD34 + progenitor cells by cytotoxic T lymphocytes specific for WT1

Liquan Gao, Ilaria Bellantuono, Annika Elsässer, Stephen B. Marley, Myrtle Y. Gordon, John M. Goldman, Hans J. Stauss

Blood (2000) 95 (7): 2198–2203.

https://doi.org/10.1182/blood.V95.7.2198

Published: 2000

Journal Articles

Allo-Major Histocompatibility Complex–Restricted Cytotoxic T Lymphocytes Engraft in Bone Marrow Transplant Recipients Without Causing Graft-Versus-Host Disease

Liquan Gao, Tian-Hui Yang, Sophie Tourdot, Elena Sadovnikova, Robert Hasserjian, Hans J. Stauss

Blood (1999) 94 (9): 2999–3006.

https://doi.org/10.1182/blood.V94.9.2999

Published: 1999

NARROW

No hiding place for BOB inside myeloma

Optimizing T-cell receptor gene therapy for hematologic malignancies

Engineered T cells can fight malignant T cells

CD3 limits the efficacy of TCR gene therapy in vivo

Human T cells expressing affinity-matured TCR display accelerated responses but fail to recognize low density of MHC-peptide antigen

Specificity for the tumor-associated self-antigen WT1 drives the development of fully functional memory T cells in the absence of vaccination

DNA vaccination induces WT1-specific T-cell responses with potential clinical relevance

LMP2-Specific TCR Gene Therapy for Hodgkin Lymphoma - Design of a Dominant TCR Construct for Immunotherapy.

Modulation of human dendritic-cell function following transduction with viral vectors: implications for gene therapy

Immunotargetting of the Wilms’ Tumor WT1 Antigen for Dendritic Cell and B-Cell-Based Vaccination of Leukemia.

Escherichia Coli Expressing Recombinant WT1 Protein and Listeriolysin O Stimulate Antigen-Specific T Cells Following Vaccination in C57BL/6 Mice.

Use of B cell–bound HLA-A2 class I monomers to generate high-avidity, allo-restricted CTLs against the leukemia-associated protein Wilms tumor antigen

TCR gene therapy of leukemia

Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity

Two distinct HLA-A0201–presented epitopes of the Wilms tumor antigen 1 can function as targets for leukemia-reactive CTL

Selective elimination of leukemic CD34 + progenitor cells by cytotoxic T lymphocytes specific for WT1

Allo-Major Histocompatibility Complex–Restricted Cytotoxic T Lymphocytes Engraft in Bone Marrow Transplant Recipients Without Causing Graft-Versus-Host Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only